Overview
Metrion Biosciences is a UK-based contract research organization specializing in preclinical ion channel drug discovery services for pharmaceutical and biotech clients worldwide. They offer comprehensive solutions from high-throughput screening using advanced platforms like FLIPR Penta and Sophion Qube 384 to IND-enabling studies, cardiac safety profiling, and neuroscience research. Their capabilities include automated electrophysiology, fluorescence-based assays, and work with human stem cells and native tissues from a single research hub.
Frequently asked questions
- What ion channel screening capabilities does Metrion offer?
- Metrion provides high-throughput screening in 384-well formats using FLIPR Penta for fluorescence-based assays and Sophion Qube 384 for automated electrophysiology, alongside QPatch systems and low-volume liquid handling.
- What therapeutic areas does Metrion support?
- Metrion specializes in cardiac safety profiling, neuroscience research, and ion channel drug discovery, including work with human stem cells and native tissues for translational studies.
- Where is Metrion located and does it serve global clients?
- Metrion operates from a single state-of-the-art research hub in the UK and delivers services to pharmaceutical and bioscience customers worldwide.